FBIO Fortress Biotech Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: FBIO

Price (delayed)

$2.725

Market cap

$90.88M

P/E Ratio

0.84

Dividend/share

N/A

EPS

$3.26

Enterprise value

-$53.6M

?
Relative Growth: Rel. Growth: 51
Relative Strength: Rel. Strength: 36
Relative Valuation: Rel. Valuation: 91
Relative Profitability: Rel. Profitability: 91

Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty ...

Highlights
FBIO's quick ratio has soared by 136% YoY and by 38% QoQ
The debt has decreased by 23% YoY
Fortress Biotech's EPS has decreased by 15% QoQ
FBIO's net income is down by 12% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.fortressbiotech.com
Peers: VCYT ALKS

Key stats

What are the main financial stats of FBIO

FBIO stock price

How has the Fortress Biotech stock price performed over time
Intraday
-0.18%
1 week
-2.68%
1 month
-1.27%
1 year
-7.63%
YTD
-25.55%
QTD
-10.95%

Financial performance

How have Fortress Biotech's revenue and profit performed over time
Revenue
$68.47M
Gross profit
$44.91M
Operating income
-$29.35M
Net income
$111.82M
Gross margin
65.6%
Net margin
163.3%
FBIO's operating margin has surged by 76% year-on-year and by 49% since the previous quarter
FBIO's operating income has soared by 72% YoY and by 47% from the previous quarter
The net margin has decreased by 15% QoQ
FBIO's revenue is up by 15% year-on-year and by 3.5% since the previous quarter

Price vs fundamentals

How does FBIO's price correlate with its fundamentals

Growth

What is Fortress Biotech's growth rate over time

Valuation

What is Fortress Biotech stock price valuation
P/E
0.84
P/B
0.55
P/S
1.27
EV/EBIT
-0.43
EV/EBITDA
-0.4
EV/Sales
-0.78
Fortress Biotech's EPS has decreased by 15% QoQ
The P/B is 71% less than the 5-year quarterly average of 1.9 and 61% less than the last 4 quarters average of 1.4
The P/S is 15% below the last 4 quarters average of 1.5 but 6% above the 5-year quarterly average of 1.2
FBIO's revenue is up by 15% year-on-year and by 3.5% since the previous quarter

Efficiency

How efficient is Fortress Biotech business performance
The company's return on equity fell by 37% QoQ
The ROA has declined by 26% since the previous quarter
FBIO's return on invested capital is down by 17% since the previous quarter
Fortress Biotech's return on sales has decreased by 15% QoQ

Dividends

What is FBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FBIO.

Financial health

How did Fortress Biotech financials performed over time
The total assets is 186% more than the total liabilities
FBIO's quick ratio has soared by 136% YoY and by 38% QoQ
Fortress Biotech's current ratio has soared by 106% YoY and by 38% from the previous quarter
The debt is 68% lower than the equity
The debt to equity has dropped by 80% year-on-year and by 3% since the previous quarter
The debt has decreased by 23% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.